Abstract | BACKGROUND: OBJECTIVE: To evaluate the frequency of anticardiolipin (aCL) or anti-beta-2 glycoprotein I (anti-beta2GPI) antibodies in a cohort of patients with primary (PAPS) and secondary (SAPS) antiphospholipid syndrome and other rheumatic and infectious conditions. METHODS: Sera were drawn from 226 patients with PAPS (n= 66), SAPS (n= 60), rheumatoid arthritis (RA) ( n= 30), scleroderma (SSc) ( n= 30) or syphilis ( n= 30). IgG, IgM, IgA aCL and anti-beta2GPI antibodies were determined for all patients. We employed Varelisa diagnostic kits (Pharmacia Diagnostics GmbH & Co.KG, Germany). RESULTS: In APS patients: aCL and anti-betaGP1 antibodies were detected in 81.8% and 70% in PAPS and SAPS patients, respectively. In PAPS, aCL were detected in 71.2%, and anti-beta2GP1 in 50% of patients. In SAPS, aCL were detected in 63.3%, and anti-beta2GP1 in 53.3% of patients. In syphilis, aCL and anti-beta2GP1 antibodies were detected in 46.7% of patients in low levels: aCL in 36.7% and anti-beta2GP1 in 20% of patients. aCL antibodies were detected in 10%, 13.3%, and 0% of RA patients, SSc patients, and healthy persons, respectively. Anti-beta2GP1 antibodies were not detected in RA patients, SSc patients, and healthy persons. CONCLUSIONS: aCL and anti-beta2GP1 antibodies are more frequently found in sera of APS patients, and can be found in low levels in syphilis. Anti-beta2GP1 assay found to be more specific than aCL in antiphospholipid antibodies determination.
|
Authors | I Marai, B Gilburd, M Blank, Y Shoenfeld |
Journal | Human antibodies
(Hum Antibodies)
Vol. 12
Issue 3
Pg. 57-62
( 2003)
ISSN: 1093-2607 [Print] Netherlands |
PMID | 14646033
(Publication Type: Journal Article)
|
Chemical References |
- Autoantibodies
- Cardiolipins
- Glycoproteins
- beta 2-Glycoprotein I
|
Topics |
- Antiphospholipid Syndrome
(blood, diagnosis, immunology)
- Arthritis, Rheumatoid
(immunology)
- Autoantibodies
(immunology)
- Cardiolipins
(immunology)
- Cohort Studies
- Glycoproteins
(immunology)
- Humans
- Scleroderma, Systemic
(immunology)
- Syphilis
(immunology)
- beta 2-Glycoprotein I
|